N-Methyl-D-aspartic Acid (NMDA) Receptor Is Involved in the Inhibitory Effect of Ketamine on Human Sperm Functions

Ketamine, which used to be widely applied in human and animal medicine as a dissociative anesthetic, has become a popular recreational drug because of its hallucinogenic effect. Our previous study preliminarily proved that ketamine could inhibit human sperm function by affecting intracellular calcium concentration ([Ca2+](i)). However, the specific signaling pathway of [Ca2+](i) induced by ketamine in human sperm is still not clear yet. Here, the N-methyl-d-aspartic acid (NMDA) receptor was detected in the tail region of human sperm. Its physiological ligand, NMDA (50 mu M), could reverse ketamine's inhibitory effect on human sperm function, and its antagonist, MK801 (100 mu M), could restrain the effect of NMDA. The inhibitory effect caused by 4 mM ketamine or 100 mu M MK801 on [Ca2+](i), which is a central factor in the regulation of human sperm function, could also be recovered by 50 mu M NMDA. The results suggest that the NMDA receptor is probably involved in the inhibitory effect of ketamine on human sperm functions.

Automated summary

The study found that the N-methyl-D-aspartic acid receptor may be involved in the inhibitory effect of ketamine on human sperm function, while NMDA can reverse the inhibitory effect of ketamine.